Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis

被引:0
|
作者
Juanzhi Fang
Stephanie Korrer
Jonathan C. Johnson
Mark A. Cheadle
Roshani Shah
Matias L. Ferraris
Cristina Lopez-Lopez
机构
[1] Novartis Pharmaceuticals Corporation,
[2] Optum,undefined
[3] Novartis Pharma AG,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Acute; Comorbidity; Erenumab; Migraine; Observational; Preventive; Real world; Retrospective;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2921 / 2934
页数:13
相关论文
共 50 条
  • [1] Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis
    Juanzhi Fang
    Stephanie Korrer
    Jonathan C. Johnson
    Mark A. Cheadle
    Roshani Shah
    Matias L. Ferraris
    Cristina Lopez-Lopez
    Advances in Therapy, 2021, 38 : 4598 - 4598
  • [2] Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis
    Juanzhi Fang
    Stephanie Korrer
    Jonathan C. Johnson
    Mark A. Cheadle
    Roshani Shah
    Matias L. Ferraris
    Cristina Lopez-Lopez
    Advances in Therapy, 2021, 38 : 2935 - 2935
  • [3] Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis (vol 38, pg 2921, 2021)
    Fang, Juanzhi
    Korrer, Stephanie
    Johnson, Jonathan C.
    Cheadle, Mark A.
    Shah, Roshani
    Ferraris, Matias L.
    Lopez-Lopez, Cristina
    ADVANCES IN THERAPY, 2021, 38 (08) : 4598 - 4598
  • [4] Real-world Trends in Characteristics of Migraine Patients Newly Initiated on Erenumab in the United States
    Fang, J.
    Korrer, S.
    Johnson, J.
    Vo, P.
    Cheadle, A.
    Shah, R.
    Ferraris, M.
    Lopez, C. Lopez
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 159 - 159
  • [5] Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis (Mar, 10.1007/s12325-021-01677-y, 2021)
    Fang, Juanzhi
    Korrer, Stephanie
    Johnson, Jonathan C.
    Cheadle, Mark A.
    Shah, Roshani
    Ferraris, Matias L.
    Lopez-Lopez, Cristina
    ADVANCES IN THERAPY, 2021, 38 (06) : 2935 - 2935
  • [6] Retrospective Real-World Evaluation Of Erenumab In Refractory Chronic Migraine
    Ong, Hui Ching
    Ghadiri-Sani, Mona
    CEPHALALGIA, 2023, 43 (1supp)
  • [7] Real-world effectiveness of erenumab in Japanese patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Shiina, Tomohiko
    Haruyama, Yasuo
    Kobayashi, Saro
    Shioda, Mukuto
    Hirata, Koichi
    HELIYON, 2024, 10 (04)
  • [8] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
    Gladstone, Jonathan
    Chhibber, Sameer
    Minhas, Jagdeep
    Neish, Calum S.
    Power, G. Sarah
    Lan, Zhiyi
    Rochdi, Driss
    Lanthier-Martel, Jessica
    Bastien, Natacha
    HEADACHE, 2022, 62 (01): : 78 - 88
  • [9] A prospective real-world analysis of erenumab in refractory chronic migraine
    Lambru, Giorgio
    Hill, Bethany
    Murphy, Madeleine
    Tylova, Ivona
    Andreou, Anna P.
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [10] A prospective real-world analysis of erenumab in refractory chronic migraine
    Giorgio Lambru
    Bethany Hill
    Madeleine Murphy
    Ivona Tylova
    Anna P. Andreou
    The Journal of Headache and Pain, 2020, 21